Manufacturer of Idrasil™, the first standardized medical cannabis, launches after 14 years of research and development, takes aim at U.S. pharmaceutical industry and its opioid epidemic. ANAHEIM, Calif., Sept. 17, 2024 /PRNewswire/ — C3 Pharmaceuticals, Inc., a private biopharmaceutical…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.